Jackson Square Capital
GH icon

Jackson Square Capital’s Guardant Health GH Stock Holding History

Jackson Square Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$451K Buy
+2,531
New +$414K 0.07% 113

Other funds holding GH

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Triasima Portfolio Management
Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
MRA Advisory Group
MRA Advisory Group Parsippany, New Jersey $267M AUM 19.2% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

Jackson Square Capital's GH Position: Q3 2026 in Review

Jackson Square Capital opened a new position in Guardant Health (GH) in Q3 2026: 2,531 shares worth $451K. The stake represents 0.07% of the portfolio and ranks #113 among its holdings.

88 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Jackson Square Capital held 2,531 shares of Guardant Health worth $451K as of Q3 2026.
  • Guardant Health was a new Jackson Square Capital position in Q3 2026.
  • Guardant Health made up 0.07% of Jackson Square Capital's portfolio in Q3 2026, its #113 holding.
  • 88 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.